by Karin L. Schiøler, Michael Alifrangis, Uriel Kitron, Flemming Konradsen
Neglected Tropical Diseases
Angola is grappling with a yellow fever outbreak, which has infected more than 450 people and killed 178 – the first epidemic of the disease to hit the country in 30 years. The outbreak, which was first reported in the capital city Luanda in December 2015, has since spread to 6 of the country’s 18
Unexplained meat bans can alienate people and hurt livelihoods. Salome Bukachi proposes ways to improve response.
by Colin J. Carlson, Eric R.
by Inge Kroidl, Elmar Saathoff, Lucas Maganga, Petra Clowes, Leonard Maboko, Achim Hoerauf, Williams H. Makunde, Antelmo Haule, Prisca Mviombo, Bettina Pitter, Neema Mgeni, Joseph Mabuye, Dickens Kowuor, Upendo Mwingira, Mwelecele N. Malecela, Thomas Löscher, Michael Hoelscher
by Qiang Wan, Lihua Xiao, Xichen Zhang, Yijing Li, Yixin Lu, Mingxin Song, Wei Li Enterocytozoon bieneusi is a widespread parasite with high genetic diversity among hosts. Its natural reservoir remains elusive and data on population structure are available only in isolates from primates. Here we describe a population genetic study of 101 E
by Vipa Thanachartwet, Varunee Desakorn, Duangjai Sahassananda, Akanitt Jittmittraphap, Nittha Oer-areemitr, Sathaporn Osothsomboon, Manoon Surabotsophon, Anan Wattanathum Background Currently, there are no biomarkers that can predict the incidence of dengue shock and/or organ failure, although the early identification of risk factors is important in determining appropriate management to reduce mortality. Therefore, we sought to determine the factors associated with dengue shock and/or organ failure and to evaluate the prognostic value of serum procalcitonin (PCT) and peripheral venous lactate (PVL) levels as biomarkers of dengue shock and/or organ failure.
by Zachary A. Klase, Svetlana Khakhina, Adriano De Bernardi Schneider, Michael V. Callahan, Jill Glasspool-Malone, Robert Malone The ongoing Zika virus epidemic in the Americas and the observed association with both fetal abnormalities (primary microcephaly) and adult autoimmune pathology (Guillain–Barré syndrome) has brought attention to this neglected pathogen
by Jacqueline Deen, Martin W. Weber, Thomas Jaenisch
by Priyanka Mehta, Peter J. Hotez
by Jin-ren Pan, Ju-ying Yan, Jia-yue Zhou, Xue-wen Tang, Han-qing He, Rong-hui Xie, Hai-yan Mao, Yan-jun Zhang, Shu-yun Xie Background Sporadic Japanese encephalitis (JE) cases still have been reported in Zhejiang Province in recent years, and concerns about vaccine cross-protection and population-level immunity have been raised off and on within the public health sphere. Genotype I (GI) has replaced GIII as the dominant genotype in Asian countries during the past few decades, which caused considerable concerns about the potential change of epidemiology characteristics and the vaccine effectiveness. The aim of this study was to investigate the prevalence of JE neutralizing antibody and its waning antibody trend after live attenuated JE vaccine immunization.
by Patrick C. Y. Woo, Susanna K
by Marie-Marie Olive, Véronique Chevalier, Vladimir Grosbois, Annelise Tran, Soa-Fy Andriamandimby, Benoit Durand, Jean-Pierre Ravalohery, Seta Andriamamonjy, Fanjasoa Rakotomanana, Christophe Rogier, Jean-Michel Heraud
by Reeta Subramaniam Mani
by Esther M. Ellis, Tyler M.
by Olga V. Viktorovskaya, Todd M.
by Veronica Schmitz, Rhana Berto da Silva Prata, Mayara Garcia de Mattos Barbosa, Mayara Abud Mendes, Sheila Santos Brandão, Thaís Porto Amadeu, Luciana Silva Rodrigues, Helen Ferreira, Fabrício da Mota Ramalho Costa, Jessica Brandão dos Santos, Fabiana dos Santos Pacheco, Alice de Miranda Machado, José Augusto da Costa Nery, Mariana de Andrea Hacker, Anna Maria Sales, Roberta Olmo Pinheiro, Euzenir Nunes Sarno Erythema Nodosum Leprosum (ENL) is an immune reaction in leprosy that aggravates the patient´s clinical condition. ENL presents systemic symptoms of an acute infectious syndrome with high leukocytosis and intense malaise clinically similar to sepsis. The treatment of ENL patients requires immunosuppression and thus needs to be early and efficient to prevent both disabilities and permanent nerve damage